Cargando…
Reversing the “Risk‐Treatment Paradox” of Bleeding in Patients Undergoing Percutaneous Coronary Intervention: Risk‐Concordant Use of Bleeding Avoidance Strategies Is Associated With Reduced Bleeding and Lower Costs
BACKGROUND: Bleeding is a common, morbid, and costly complication of percutaneous coronary intervention. While bleeding avoidance strategies (BAS) are effective, they are used paradoxically less in patients at high risk of bleeding. Whether a patient‐centered approach to specifically increase the ri...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6404202/ https://www.ncbi.nlm.nih.gov/pubmed/30376760 http://dx.doi.org/10.1161/JAHA.118.008551 |
_version_ | 1783400824089608192 |
---|---|
author | Amin, Amit P. Miller, Samantha Rahn, Brandon Caruso, Mary Pierce, Andrew Sorensen, Katrine Kurz, Howard Zajarias, Alan Bach, Richard Singh, Jasvindar Lasala, John M. Kulkarni, Hemant Crimmins‐Reda, Patricia |
author_facet | Amin, Amit P. Miller, Samantha Rahn, Brandon Caruso, Mary Pierce, Andrew Sorensen, Katrine Kurz, Howard Zajarias, Alan Bach, Richard Singh, Jasvindar Lasala, John M. Kulkarni, Hemant Crimmins‐Reda, Patricia |
author_sort | Amin, Amit P. |
collection | PubMed |
description | BACKGROUND: Bleeding is a common, morbid, and costly complication of percutaneous coronary intervention. While bleeding avoidance strategies (BAS) are effective, they are used paradoxically less in patients at high risk of bleeding. Whether a patient‐centered approach to specifically increase the risk‐concordant use of BAS and, thus, reverse the risk‐treatment paradox is associated with reduced bleeding and costs is unknown. METHODS AND RESULTS: We implemented an intervention to reverse the bleeding risk‐treatment paradox at Barnes‐Jewish Hospital, St. Louis, MO, and examined: (1) the temporal trends in BAS use and (2) the association of risk‐concordant BAS use with bleeding and hospital costs of percutaneous coronary intervention. Among 3519 percutaneous coronary interventions, there was a significantly increasing trend (P=0.002) in risk‐concordant use of BAS. The bleeding incidence was 2% in the risk‐concordant group versus 9% in the risk‐discordant group (absolute risk difference, 7%; number needed to treat, 14). Risk‐concordant BAS use was associated with a 67% (95% confidence interval, 52–78%; P<0.001) reduction in the risk of bleeding and a $4738 (95% confidence interval, 3353–6122; P<0.001) reduction in per‐patient percutaneous coronary intervention hospitalization costs (21.6% cost‐savings). CONCLUSIONS: In this study, patient‐centered care directly aimed to make treatment‐related decisions based on predicted risk of bleeding, led to more risk‐concordant use of BAS and reversal of the risk‐treatment paradox. This, in turn, was associated with a reduction in bleeding and hospitalization costs. Larger multicentered studies are needed to corroborate these results. As clinical medicine moves toward personalization, both patients and hospitals can benefit from a simple practice change that encourages objectivity and mitigates variability in care. |
format | Online Article Text |
id | pubmed-6404202 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-64042022019-03-18 Reversing the “Risk‐Treatment Paradox” of Bleeding in Patients Undergoing Percutaneous Coronary Intervention: Risk‐Concordant Use of Bleeding Avoidance Strategies Is Associated With Reduced Bleeding and Lower Costs Amin, Amit P. Miller, Samantha Rahn, Brandon Caruso, Mary Pierce, Andrew Sorensen, Katrine Kurz, Howard Zajarias, Alan Bach, Richard Singh, Jasvindar Lasala, John M. Kulkarni, Hemant Crimmins‐Reda, Patricia J Am Heart Assoc Original Research BACKGROUND: Bleeding is a common, morbid, and costly complication of percutaneous coronary intervention. While bleeding avoidance strategies (BAS) are effective, they are used paradoxically less in patients at high risk of bleeding. Whether a patient‐centered approach to specifically increase the risk‐concordant use of BAS and, thus, reverse the risk‐treatment paradox is associated with reduced bleeding and costs is unknown. METHODS AND RESULTS: We implemented an intervention to reverse the bleeding risk‐treatment paradox at Barnes‐Jewish Hospital, St. Louis, MO, and examined: (1) the temporal trends in BAS use and (2) the association of risk‐concordant BAS use with bleeding and hospital costs of percutaneous coronary intervention. Among 3519 percutaneous coronary interventions, there was a significantly increasing trend (P=0.002) in risk‐concordant use of BAS. The bleeding incidence was 2% in the risk‐concordant group versus 9% in the risk‐discordant group (absolute risk difference, 7%; number needed to treat, 14). Risk‐concordant BAS use was associated with a 67% (95% confidence interval, 52–78%; P<0.001) reduction in the risk of bleeding and a $4738 (95% confidence interval, 3353–6122; P<0.001) reduction in per‐patient percutaneous coronary intervention hospitalization costs (21.6% cost‐savings). CONCLUSIONS: In this study, patient‐centered care directly aimed to make treatment‐related decisions based on predicted risk of bleeding, led to more risk‐concordant use of BAS and reversal of the risk‐treatment paradox. This, in turn, was associated with a reduction in bleeding and hospitalization costs. Larger multicentered studies are needed to corroborate these results. As clinical medicine moves toward personalization, both patients and hospitals can benefit from a simple practice change that encourages objectivity and mitigates variability in care. John Wiley and Sons Inc. 2018-10-31 /pmc/articles/PMC6404202/ /pubmed/30376760 http://dx.doi.org/10.1161/JAHA.118.008551 Text en © 2018 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
spellingShingle | Original Research Amin, Amit P. Miller, Samantha Rahn, Brandon Caruso, Mary Pierce, Andrew Sorensen, Katrine Kurz, Howard Zajarias, Alan Bach, Richard Singh, Jasvindar Lasala, John M. Kulkarni, Hemant Crimmins‐Reda, Patricia Reversing the “Risk‐Treatment Paradox” of Bleeding in Patients Undergoing Percutaneous Coronary Intervention: Risk‐Concordant Use of Bleeding Avoidance Strategies Is Associated With Reduced Bleeding and Lower Costs |
title | Reversing the “Risk‐Treatment Paradox” of Bleeding in Patients Undergoing Percutaneous Coronary Intervention: Risk‐Concordant Use of Bleeding Avoidance Strategies Is Associated With Reduced Bleeding and Lower Costs |
title_full | Reversing the “Risk‐Treatment Paradox” of Bleeding in Patients Undergoing Percutaneous Coronary Intervention: Risk‐Concordant Use of Bleeding Avoidance Strategies Is Associated With Reduced Bleeding and Lower Costs |
title_fullStr | Reversing the “Risk‐Treatment Paradox” of Bleeding in Patients Undergoing Percutaneous Coronary Intervention: Risk‐Concordant Use of Bleeding Avoidance Strategies Is Associated With Reduced Bleeding and Lower Costs |
title_full_unstemmed | Reversing the “Risk‐Treatment Paradox” of Bleeding in Patients Undergoing Percutaneous Coronary Intervention: Risk‐Concordant Use of Bleeding Avoidance Strategies Is Associated With Reduced Bleeding and Lower Costs |
title_short | Reversing the “Risk‐Treatment Paradox” of Bleeding in Patients Undergoing Percutaneous Coronary Intervention: Risk‐Concordant Use of Bleeding Avoidance Strategies Is Associated With Reduced Bleeding and Lower Costs |
title_sort | reversing the “risk‐treatment paradox” of bleeding in patients undergoing percutaneous coronary intervention: risk‐concordant use of bleeding avoidance strategies is associated with reduced bleeding and lower costs |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6404202/ https://www.ncbi.nlm.nih.gov/pubmed/30376760 http://dx.doi.org/10.1161/JAHA.118.008551 |
work_keys_str_mv | AT aminamitp reversingtherisktreatmentparadoxofbleedinginpatientsundergoingpercutaneouscoronaryinterventionriskconcordantuseofbleedingavoidancestrategiesisassociatedwithreducedbleedingandlowercosts AT millersamantha reversingtherisktreatmentparadoxofbleedinginpatientsundergoingpercutaneouscoronaryinterventionriskconcordantuseofbleedingavoidancestrategiesisassociatedwithreducedbleedingandlowercosts AT rahnbrandon reversingtherisktreatmentparadoxofbleedinginpatientsundergoingpercutaneouscoronaryinterventionriskconcordantuseofbleedingavoidancestrategiesisassociatedwithreducedbleedingandlowercosts AT carusomary reversingtherisktreatmentparadoxofbleedinginpatientsundergoingpercutaneouscoronaryinterventionriskconcordantuseofbleedingavoidancestrategiesisassociatedwithreducedbleedingandlowercosts AT pierceandrew reversingtherisktreatmentparadoxofbleedinginpatientsundergoingpercutaneouscoronaryinterventionriskconcordantuseofbleedingavoidancestrategiesisassociatedwithreducedbleedingandlowercosts AT sorensenkatrine reversingtherisktreatmentparadoxofbleedinginpatientsundergoingpercutaneouscoronaryinterventionriskconcordantuseofbleedingavoidancestrategiesisassociatedwithreducedbleedingandlowercosts AT kurzhoward reversingtherisktreatmentparadoxofbleedinginpatientsundergoingpercutaneouscoronaryinterventionriskconcordantuseofbleedingavoidancestrategiesisassociatedwithreducedbleedingandlowercosts AT zajariasalan reversingtherisktreatmentparadoxofbleedinginpatientsundergoingpercutaneouscoronaryinterventionriskconcordantuseofbleedingavoidancestrategiesisassociatedwithreducedbleedingandlowercosts AT bachrichard reversingtherisktreatmentparadoxofbleedinginpatientsundergoingpercutaneouscoronaryinterventionriskconcordantuseofbleedingavoidancestrategiesisassociatedwithreducedbleedingandlowercosts AT singhjasvindar reversingtherisktreatmentparadoxofbleedinginpatientsundergoingpercutaneouscoronaryinterventionriskconcordantuseofbleedingavoidancestrategiesisassociatedwithreducedbleedingandlowercosts AT lasalajohnm reversingtherisktreatmentparadoxofbleedinginpatientsundergoingpercutaneouscoronaryinterventionriskconcordantuseofbleedingavoidancestrategiesisassociatedwithreducedbleedingandlowercosts AT kulkarnihemant reversingtherisktreatmentparadoxofbleedinginpatientsundergoingpercutaneouscoronaryinterventionriskconcordantuseofbleedingavoidancestrategiesisassociatedwithreducedbleedingandlowercosts AT crimminsredapatricia reversingtherisktreatmentparadoxofbleedinginpatientsundergoingpercutaneouscoronaryinterventionriskconcordantuseofbleedingavoidancestrategiesisassociatedwithreducedbleedingandlowercosts |